
Roy Baynes
Senior VP and Head, Global Clinical Development, CMO, Merck

Marcus Bosenberg
Interim Director, Yale Center for Immuno-Oncology, Yale Univ.

Dean Bottino
Sr. Scientific Director, Clinical Translational Modeling, Takeda

Virna Cortez-Retamozo
Lab Head, Oncology-Pharmacology, Sanofi

David Fontana
VP, Cell Therapy Franchise, Juno Therapeutics, a Bristol Myers Squibb Co.

Adil Daud
Director, Melanoma Clinical Research, UCSF Helen Diller Family Comprehensive Cancer Center

Cara Haymaker
Director, Oncology Research and Immuno-Monitoring Core (ORION), Univ. of Texas MD Anderson Cancer Center

Howard L. Kaufman
Head, R&D, Immuneering; Massachusetts General Hospital

Keith Knutson
Director, Immunology & Immunotherapy, Mayo Clinic

Ravi Madan
Clinical Director, Genitourinary Malignancies Branch, NCI NIH

Robert Pierce
CSO, Sensei Biotherapeutics

David A. Reardon
Clinical Director, Center for Neuro-Oncology, Dana-Farber Cancer Institute

Andrew Weinberg
Chief, Laboratory of Basic Immunology, Providence Health & Services

Theresa Whiteside
Professor, Pathology, Immunology, Univ. of Pittsburgh School of Medicine

Michael Woo
Head, Search & Evaluation, Novartis